Intellia Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 BEAM
|
Beam Therapeutics Inc. | $23.41 | $1.91 B | -14.51 | 461 | $377.71 M |
 CRBU
|
Caribou Biosciences, Inc. | $1.87 | $176.12 M | -1.41 | 158 | $34.48 M |
 CRSP
|
CRISPR Therapeutics AG | $45.36 | $4.91 B | -21.43 | 407 | $370.00 M |
 DNA
|
Ginkgo Bioworks Holdings, Inc. | $8.35 | $1.14 B | -1.2 | 1218 | $251.46 M |
 EDIT
|
Editas Medicine, Inc. | $3.39 | $435.86 M | -2.56 | 265 | $78.12 M |
 FATE
|
Fate Therapeutics, Inc. | $3.23 | $418.90 M | -1.92 | 181 | $63.53 M |
 PRME
|
Prime Medicine, Inc. | $3.50 | $788.60 M | -3.01 | 234 | $0 |
 SANA
|
Sana Biotechnology, Inc. | $4.25 | $1.55 B | -4.59 | 328 | $0 |
 VERV
|
Verve Therapeutics, Inc. | $5.01 | $409.24 M | -1.82 | 255 | $11.76 M |
 VRTX
|
Vertex Pharmaceuticals Incorporated | $455.31 | $124.65 B | 31.39 | 5400 | $9.84 B |